ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Adnan-Mustafiz Chowdhury, Sattam A Halaseh, Debora Joseph, Abel I Abel, Nikita Jha, Amro Al-Karadsheh, Hakam Al-Karadsheh, Omar A Salem, Sama F Salaitah, Noor M Arman, Georges Rizkallah
Koreddi A Dora, Vaka Rajashekhar, Mahadevapura R Kaushik, Gaurav Vora, Arti Sarin, Amol Patel
Rachael O Oduyemi, Chizoma Millicent Ndikom, Gloria Oluwakorede Alao, Iyanuoluwa O Ojo, Faith Ayomide Ajayi, Damilola Ajibade, Abdullahi Suleiman, Hameedah Ayomide Gbadamosi, Oluwadamilare Akingbade
Kaio Mota-Ribeiro, Maria P Curado, Betine P M Iser, Mohsen Naghavi, Deborah C Malta, Max M Oliveira